Dr. Richard Sweet received his M.D. at the University of Minnesota. He then completed his Internship, a three year Residency in Internal Medicine, and a two year Fellowship in Nephrology. Dr. Sweet became Board Certified in Internal Medicine, Nephrology, and Critical Care Medicine. He was the founder of the largest nephrology practice in Minnesota, the Kidney Specialists of Minnesota, and while there he was instrumental in developing a drug study program, Twin Cities Clinical Research. During this time Dr. Sweet participated in over 12 clinical trials including the use of therapeuitic monoclonal antibodies to treat sepsis and a trial natriuretic peptide in acute renal failure.

Dr. Sweet was Co-Director of Renal Transplantation at Abbott Northwestern Hospital in Minneapolis, and he helped found the Renal Transplant Program at the hospital. Dr. Sweet also founded one of the largest apheresis programs in the United States, and has given a number of presentations in extracorporeal filtration and immunoaffinity absorption.

Dr. Sweet is currently an Associate Clincal Professor of Medicine at the University of California, San Fransisco, Chief Medical Officer of Hemotherapeutics, Los Angeles, CA, and Chief Medical Officer at R&D Antibodies LLC, Las Vegas, NV. Dr. Sweet also serves on the Board of Directors at R4Vascular, Minneapolis, MN.